Masamichi Kimura

8PUBLICATIONS
5CO-AUTHORS
Innate immunityMolecular targetsMedical virologyRespiratory diseasesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 06, 2026
Conserved minimal CD8 cytotoxic immune-state unit in an IL18R1-associated immune program in hepatocellular carcinoma.

|Apr 23, 2026
Combined administration of interleukin-2 and 18 with anti-PD-L1 antibody induces CCL5-positive CD8 T cells to suppress liver tumors.

|Mar 23, 2026
Non-cirrhotic portal-splenic-mesenteric vein thrombosis unmasking JAK2 V617F-positive polycythemia vera.

Tomoki Otake, Masamichi Kimura, Koji Nishikawa

|Apr 24, 2025
A case of Budd-Chiari syndrome with acute venous thrombosis and liver failure: highlighting the importance of early intervention and anticoagulation therapy.

Yumi Otoyama, Masamichi Kimura, Koji Nishikawa

|Sep 20, 2024
Frontline evaluation: Atezolizumab-bevacizumab versus lenvatinib for BCLC stage B hepatocellular carcinoma exceeding the up-to-seven criteria.

Masamichi Kimura, Koji Nishikawa, Jun Imamura

|Jan 23, 2024
Stem Cell Growth Factor-β as a Predictive Biomarker of Response to Chemotherapy and Prognosis in Patients with Advanced-Stage Hepatocellular Carcinoma: A Retrospective Study.

Masamichi Kimura, Koji Nishikawa, Jun Imamura

Pageof 2

Frequent Collaborators

3 joint publications

Kiminori Kimura

1 joint publications

Hideya Kawaji

1 joint publications

Jun Imamura

1 joint publications

Yoshimasa Tanaka